Empowered
by Movement
Our Vision
People with spinal cord injury will enjoy life in the ways that matter to them
Discover our Therapy
ARC Therapy is targeted stimulation of the spinal cord designed to restore movement, function, and independence in people living with spinal cord injury.
Meet our Team
We are a team of scientists, engineers, and physicians, collectively driven to create therapies that change lives.
We are driven to innovate, with 10 FDA Breakthrough Device Designation awards and nearly 400 issued or pending patents.
Up-LIFT pivotal trial results published in Nature Medicine
The Up-LIFT study was designed to evaluate the safety and effectiveness of our ARCEX Therapy to improve hand sensation and strength in people with chronic incomplete tetraplegia. The global study was conducted with 65 participants at 14 leading SCI centers in the US, Europe, and Canada.
Highlights** include:
-Primary safety and effectiveness endpoints met.
-90% of participants improved strength or function of their upper limbs.
-Upper extremity sensory scores improved significantly with device use.
-87% of participants reported improvement in quality of life.
-Improvement was demonstrated in participants up to 34 years post-injury.
Join our Patient Registry if you are interested in our clinical trials
Support our Community Partners
Read our Publications
-
Non-invasive spinal cord electrical stimulation for arm and hand function in chronic tetraplegia: a safety and efficacy trial
Nature Medicine
-
A spinal cord neuroprosthesis for locomotor deficits due to Parkinson’s disease
Nature Medicine
-
Walking naturally after spinal cord injury using a brain–spine interface
Nature
-
The neurons that restore walking after paralysis
Nature
View our Media Coverage
-
FDA clears game-changing new spinal cord injury device
ABC News
-
ONWARD wins FDA nod for non-invasive spinal cord stim
Mass Device
-
FDA OKs novel device for non-invasive treatment of spinal cord injuries
STAT
-
Parkinson’s implant restores man’s ability to walk
BBC
-
AI implants help paralyzed patient move arms, hands
CNN This Morning
-
Miracle steps: Spinal cord implant brings hope, mobility to Parkinson’s patient
USA Today
Explore our Blog
The ONWARD® Medical ARCEX® System is cleared for use only in the United States. ONWARD ARCIM® and ARCBCI™, alone or in combination with a brain-computer interface (BCI), are investigational and not available for commercial use.
*The ARCEX System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic to improve hand sensation and strength in individuals between 18 and 75 years old that present with a chronic, non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8 inclusive).
**Moritz, Chet, et al. “Non-invasive spinal cord stimulation for arm and hand function in chronic tetraplegia: a safety and efficacy trial.” Nature Medicine. 2024.